Want to Join Our Team?
Policy
Rigorous Policy Insight. Decisive Strategy.
US healthcare policy is reshaping the commercial landscape faster than at any point in recent memory, driving change across pricing, contracting, evidence requirements, channel strategy, and patient affordability. Overlapping reforms collide in unpredictable ways, recalibrating the incentives that drive market behavior.
Blue Matter’s Policy team helps life sciences companies cut through the complexity, model the impact, and convert policy understanding into competitive advantage. We work two ways: as a dedicated policy partner on standalone engagements, and as a force multiplier embedded across our commercial, access, medical, communications, and R&D teams.

- Legislative, regulatory, and reimbursement expertise across the shifts redefining biopharma commercialization
- Cross-functional teams that link policy depth with strategy consulting rigor
- Robust data assets and modeling capabilities to quantify impact
- Deep policy expertise paired with decision science to unpack complex, overlapping policy uncertainties and stress-test strategic options
- Seamless integration with communications strategy and execution
Services
- Policy Monitoring & Analysis
Track and interpret the evolving policy landscape, with implications tailored to your product, portfolio, and pipeline.
POLICY LANDSCAPE & HORIZON SCANNING
- Comprehensive Scans of Laws and Regulations Affecting Therapeutic Areas
- Emerging Trend Identification and Policy Outlooks
- Strategic Briefings for Senior Leadership
- Targeted Policy Deep Dives
- Internal Education and Training
- Policy Strategy & External Engagement
Develop policy positions, engagement plans, and external influence strategies that drive impact.
POLICY STRATEGY DEVELOPMENT
- Policy Prioritization and Roadmap Development
- Identification of Policy Engagement Opportunities
- Development of Policy Alternatives and Novel Solutions
- Coalition and Trade Association Strategy
- Cross-Functional Alignment Workshops
SCENARIO PLANNING & RISK MITIGATION
- Policy Scenarios and Impact Assessments
- Quantitative and Qualitative Analyses
- CBO-style Scoring
- Market Impact and Customer Response Modeling Under Policy Shifts
- Mitigation Strategy Development
EXTERNAL ENGAGEMENT & INFLUENCE
- Policymaker / Stakeholder Mapping and Influence Analysis
- White Papers, Issue Briefs, Fact Sheets, Comment Letters, and Other Advocacy Materials
- Policy Narratives for Payer, Provider, and Patient Audiences
- Policy-Informed Commercial Strategy
Integrate policy into pricing, access, evidence, launch, and commercial strategy where the stakes are highest.
- Policy-Risk Overlay to Product and Portfolio Strategy, Access, and Pricing Considerations